BAY CITY CAPITAL LLC

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
BAY CITY CAPITAL LLC's trades of Xilio Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-10-26 2021-10-26
B Purchase
35,088 -38.4%
290.51
US$4,787,560 		35,088 -38.4% 290.51 US$4,787,560
2020-08-19 2020-08-19
S Sale
57,027 +21.2%
457.12
US$1,506,318 		57,027 +21.2% 457.12 US$1,506,318
2020-08-19 2020-08-18
S Sale
75,289 -27.6%
88.64
US$3,265,249 		75,289 -27.6% 88.64 US$3,265,249
2020-08-19 2020-08-17
S Sale
12,500 -17.2%
110.73
US$1,384,125 		12,500 -17.2% 110.73 US$1,384,125